Commentary
by
McAnally, Health
Release Date
2022
Geography
USA
Language of Resource
English
Full Text Available
Yes
Open Access / OK to Reproduce
No
Peer Reviewed
No
Findings/Key points
Tapentadol (Nucynta), a tramadol analog, is a weak opioid agonist (1/18th of the potency of morphine in terms of mu-opioid receptor binding/activation), but in concert with norepinephrine reuptake inhibition (NRI) it yields significantly synergistically increased analgesic efficacy, as well as reduced tolerance and reduced adverse effect profile.
Keywords
Chronic pain